Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-
Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-
B Zhang, Y L Li, Shaowei Qiu, Y T Liu et al.
Journal
Haematologica
Topics
CAR-T cell therapy research
article
Durable deep molecular response via CD19 chimeric antigen receptor T-cell therapy combined with a third-generation tyrosine kinase inhibitor in acute leukemia of ambiguous lineage with the Philadelphia chromosome: a potential strategy for transplant-
B Zhang, Y L Li, Shaowei Qiu, Y T Liu, Jianxiang Wang, Ao Zhang, H Yang, Hui Wei, Chunlin Zhou, Lili Wang, Shouyun Li, Benfa Gong, Chengcai Guo, Guangji Zhang
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Institute of Hematology & Blood Diseases Hospital (CN)
Funders
National Natural Science Foundation of China, Tianjin Science and Technology Committee